Experienced management has been involved in over 10 drug approvals Developing Bria-OTS, the first off-the-shelf personalized immunotherapy targeting advanced breast cancer Impressive results in two proof-of-concept clinical trials revealed rapid response rate, repeated following re-treatment, and excellent safety profile for Bria-IMT, BriaCell’s lead clinical candidate Unmet medical needs of advanced breast cancer estimated between $1 […]
The Stocks To Buy Now Blog
Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.